vs
Progyny, Inc.（PGNY）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Progyny, Inc.的季度营收约是Rapid7, Inc.的1.5倍（$318.4M vs $217.4M），Progyny, Inc.净利率更高（3.9% vs 1.4%，领先2.5%），Progyny, Inc.同比增速更快（6.7% vs 0.5%），Progyny, Inc.自由现金流更多（$48.6M vs $36.4M），过去两年Progyny, Inc.的营收复合增速更高（7.0% vs 3.0%）
Progyny, Inc.是总部位于美国的领先生育与家庭构建福利服务商，主要与企业雇主合作，提供试管婴儿、生育力保存、收养协助、代孕支持等综合生育相关福利方案，覆盖多个行业的雇员群体。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
PGNY vs RPD — 直观对比
营收规模更大
PGNY
是对方的1.5倍
$217.4M
营收增速更快
PGNY
高出6.2%
0.5%
净利率更高
PGNY
高出2.5%
1.4%
自由现金流更多
PGNY
多$12.2M
$36.4M
两年增速更快
PGNY
近两年复合增速
3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $318.4M | $217.4M |
| 净利润 | $12.5M | $3.1M |
| 毛利率 | 24.1% | 68.9% |
| 营业利润率 | 4.8% | 1.0% |
| 净利率 | 3.9% | 1.4% |
| 营收同比 | 6.7% | 0.5% |
| 净利润同比 | 18.5% | 44.1% |
| 每股收益（稀释后） | $0.14 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PGNYRPD
| Q4 25 | $318.4M | $217.4M | ||
| Q3 25 | $313.3M | $218.0M | ||
| Q2 25 | $332.9M | $214.2M | ||
| Q1 25 | $324.0M | $210.3M | ||
| Q4 24 | $298.4M | $216.3M | ||
| Q3 24 | $286.6M | $214.7M | ||
| Q2 24 | $304.1M | $208.0M | ||
| Q1 24 | $278.1M | $205.1M |
净利润PGNYRPD
| Q4 25 | $12.5M | $3.1M | ||
| Q3 25 | $13.9M | $9.8M | ||
| Q2 25 | $17.1M | $8.3M | ||
| Q1 25 | $15.1M | $2.1M | ||
| Q4 24 | $10.5M | $2.2M | ||
| Q3 24 | $10.4M | $15.4M | ||
| Q2 24 | $16.5M | $6.5M | ||
| Q1 24 | $16.9M | $1.4M |
毛利率PGNYRPD
| Q4 25 | 24.1% | 68.9% | ||
| Q3 25 | 23.2% | 70.2% | ||
| Q2 25 | 23.7% | 70.6% | ||
| Q1 25 | 23.4% | 71.7% | ||
| Q4 24 | 21.3% | 69.5% | ||
| Q3 24 | 20.7% | 70.6% | ||
| Q2 24 | 22.5% | 70.7% | ||
| Q1 24 | 22.4% | 70.3% |
营业利润率PGNYRPD
| Q4 25 | 4.8% | 1.0% | ||
| Q3 25 | 6.9% | 2.7% | ||
| Q2 25 | 7.3% | 1.6% | ||
| Q1 25 | 7.5% | -0.0% | ||
| Q4 24 | 5.3% | 3.4% | ||
| Q3 24 | 4.3% | 6.0% | ||
| Q2 24 | 6.8% | 2.5% | ||
| Q1 24 | 6.7% | 4.7% |
净利率PGNYRPD
| Q4 25 | 3.9% | 1.4% | ||
| Q3 25 | 4.4% | 4.5% | ||
| Q2 25 | 5.1% | 3.9% | ||
| Q1 25 | 4.6% | 1.0% | ||
| Q4 24 | 3.5% | 1.0% | ||
| Q3 24 | 3.6% | 7.2% | ||
| Q2 24 | 5.4% | 3.1% | ||
| Q1 24 | 6.1% | 0.7% |
每股收益（稀释后）PGNYRPD
| Q4 25 | $0.14 | $0.05 | ||
| Q3 25 | $0.15 | $0.15 | ||
| Q2 25 | $0.19 | $0.13 | ||
| Q1 25 | $0.17 | $0.03 | ||
| Q4 24 | $0.12 | $0.08 | ||
| Q3 24 | $0.11 | $0.21 | ||
| Q2 24 | $0.17 | $0.09 | ||
| Q1 24 | $0.17 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $112.2M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $516.0M | $154.7M |
| 总资产 | $742.4M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PGNYRPD
| Q4 25 | $112.2M | $474.7M | ||
| Q3 25 | $134.0M | $407.1M | ||
| Q2 25 | $132.5M | $511.7M | ||
| Q1 25 | $109.2M | $493.5M | ||
| Q4 24 | $162.3M | $521.7M | ||
| Q3 24 | $91.5M | $443.7M | ||
| Q2 24 | $95.0M | $442.6M | ||
| Q1 24 | $115.0M | $411.7M |
股东权益PGNYRPD
| Q4 25 | $516.0M | $154.7M | ||
| Q3 25 | $560.0M | $127.2M | ||
| Q2 25 | $515.0M | $90.4M | ||
| Q1 25 | $467.2M | $52.7M | ||
| Q4 24 | $422.1M | $17.7M | ||
| Q3 24 | $434.9M | $-5.1M | ||
| Q2 24 | $456.2M | $-52.6M | ||
| Q1 24 | $571.6M | $-86.4M |
总资产PGNYRPD
| Q4 25 | $742.4M | $1.7B | ||
| Q3 25 | $795.2M | $1.7B | ||
| Q2 25 | $761.0M | $1.6B | ||
| Q1 25 | $730.3M | $1.6B | ||
| Q4 24 | $607.1M | $1.7B | ||
| Q3 24 | $660.0M | $1.6B | ||
| Q2 24 | $698.6M | $1.5B | ||
| Q1 24 | $794.3M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.2M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $48.6M | $36.4M |
| 自由现金流率自由现金流/营收 | 15.3% | 16.8% |
| 资本支出强度资本支出/营收 | 1.8% | 0.5% |
| 现金转化率经营现金流/净利润 | 4.34× | 12.01× |
| 过去12个月自由现金流最近4个季度 | $191.8M | $146.2M |
8季度趋势，按日历期对齐
经营现金流PGNYRPD
| Q4 25 | $54.2M | $37.6M | ||
| Q3 25 | $50.7M | $39.0M | ||
| Q2 25 | $55.5M | $47.5M | ||
| Q1 25 | $49.8M | $29.8M | ||
| Q4 24 | $52.2M | $63.8M | ||
| Q3 24 | $44.5M | $44.0M | ||
| Q2 24 | $56.7M | $32.9M | ||
| Q1 24 | $25.7M | $31.1M |
自由现金流PGNYRPD
| Q4 25 | $48.6M | $36.4M | ||
| Q3 25 | $46.0M | $34.8M | ||
| Q2 25 | $50.2M | $46.6M | ||
| Q1 25 | $47.0M | $28.4M | ||
| Q4 24 | $50.3M | $62.6M | ||
| Q3 24 | $42.7M | $42.6M | ||
| Q2 24 | $55.8M | $32.6M | ||
| Q1 24 | $24.9M | $30.4M |
自由现金流率PGNYRPD
| Q4 25 | 15.3% | 16.8% | ||
| Q3 25 | 14.7% | 16.0% | ||
| Q2 25 | 15.1% | 21.8% | ||
| Q1 25 | 14.5% | 13.5% | ||
| Q4 24 | 16.8% | 28.9% | ||
| Q3 24 | 14.9% | 19.9% | ||
| Q2 24 | 18.4% | 15.7% | ||
| Q1 24 | 8.9% | 14.8% |
资本支出强度PGNYRPD
| Q4 25 | 1.8% | 0.5% | ||
| Q3 25 | 1.5% | 1.9% | ||
| Q2 25 | 1.6% | 0.4% | ||
| Q1 25 | 0.9% | 0.6% | ||
| Q4 24 | 0.6% | 0.5% | ||
| Q3 24 | 0.6% | 0.6% | ||
| Q2 24 | 0.3% | 0.1% | ||
| Q1 24 | 0.3% | 0.3% |
现金转化率PGNYRPD
| Q4 25 | 4.34× | 12.01× | ||
| Q3 25 | 3.65× | 3.97× | ||
| Q2 25 | 3.24× | 5.70× | ||
| Q1 25 | 3.31× | 14.14× | ||
| Q4 24 | 4.95× | 29.36× | ||
| Q3 24 | 4.27× | 2.85× | ||
| Q2 24 | 3.44× | 5.03× | ||
| Q1 24 | 1.52× | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
